mTOR kinase inhibition effectively decreases progression of a subset of neuroendocrine tumors that progress on rapalog therapy and delays cardiac impairment
Orr-Asman, Melissa A., Chu, Zhengtao, Jiang, Min, Worley, Mariah, LaSance, Kathleen, Koch, Sheryl E, Carreira, Vinicius S., Dahche, Hanan M., Plas, David R., Komurov, Kakajan, Qi, Xiaoyang, Mercer, CaМова:
english
Журнал:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-17-0058
Date:
September, 2017
Файл:
PDF, 6.74 MB
english, 2017
File converter
Більше результатів пошуку
More benefits 
